Halloween has come and gone in the US, and Americans are now gearing up for Thanksgiving and Christmas. But before the holiday season could get underway, the country went through a major political event with far-reaching implications: the midterm elections.As…
Maruho will begin jointly promoting Japan Tissue Engineering’s (J-TEC) vitiligo treatment Jacemin in Japan in April 2027, aiming to expand patient access through closer ties between dermatology clinics and specialist hospitals. The partnership for the regenerative medicine product was unveiled…
To read the full story
Related Article
- J-TEC to Launch Jacemin Cell Sheet for Vitiligo on Oct. 11
October 8, 2024
BUSINESS
- Tanabe to Wind Down NeuroDerm, Scrap EU Launch of Parkinson’s Drug
November 19, 2026
- Shionogi Narrows R&D Pipeline to 21 Priority Programs Across 3 Disease Areas
November 19, 2026
- Toho, SDF Hospital Conduct Emergency Drug Supply Drill
November 19, 2026
- Japan Clears Fujirebio’s Blood-Based Aβ42 Test for Alzheimer’s
November 19, 2026
- Sobi Japan to Take Over Orfadin from Astellas in December
November 19, 2026





